PDE12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.147200E-01
Normal-vs-Stage2
9.861200E-01
Normal-vs-Stage3
2.839600E-02
Normal-vs-Stage4
1.362640E-01
Stage1-vs-Stage2
5.073200E-01
Stage1-vs-Stage3
1.062020E-02
Stage1-vs-Stage4
1.637770E-01
Stage2-vs-Stage3
3.78020000000312E-05
Stage2-vs-Stage4
3.025500E-02
Stage3-vs-Stage4
1.819750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.782400E-01
Normal-vs-AfricanAmerican
5.998400E-01
Normal-vs-Asian
6.357600E-01
Caucasian-vs-AfricanAmerican
4.399800E-01
Caucasian-vs-Asian
5.484800E-01
AfricanAmerican-vs-Asian
3.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.699200E-01
Normal-vs-Female
9.478400E-01
Male-vs-Female
6.934600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.396800E-01
Normal-vs-Age(41-60Yrs)
7.295400E-01
Normal-vs-Age(61-80Yrs)
8.975000E-01
Normal-vs-Age(81-100Yrs)
4.757600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.667600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.502800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.121600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.710300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.710200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.190000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.693000E-01
Normal-vs-Daily Drinker
3.427800E-01
Normal-vs-Weekly Drinker
8.592400E-01
Normal-vs-Occasional Drinker
8.255600E-01
Normal-vs-Social Drinker
9.548400E-01
Non Drinker-vs-Daily Drinker
2.840000E-01
Non Drinker-vs-Weekly Drinker
3.174600E-01
Non Drinker-vs-Occasional Drinker
1.331590E-01
Non Drinker-vs-Social Drinker
4.128400E-01
Daily Drinker-vs-Weekly Drinker
1.321760E-01
Daily Drinker-vs-Occasional Drinker
3.923500E-02
Daily Drinker-vs-Social Drinker
1.415810E-01
Weekly Drinker-vs-Occasional Drinker
9.829000E-01
Weekly Drinker-vs-Social Drinker
6.806800E-01
Occasional Drinker-vs-Social Drinker
6.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.844150E-01
Normal-vs-Grade 2
5.844000E-02
Normal-vs-Grade 3
8.707500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.953000E-01
Grade 1-vs-Grade 3
9.714200E-01
Grade 1-vs-Grade 4
1.844150E-01
Grade 2-vs-Grade 3
6.614800E-01
Grade 2-vs-Grade 4
5.844000E-02
Grade 3-vs-Grade 4
8.707500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.647600E-01
Normal-vs-NonDiabetic
7.889200E-01
Diabetic-vs-NonDiabetic
9.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.814000E-01
Normal-vs-NoPancreatitis
8.893000E-01
Pancreatitis-vs-NoPancreatitis
3.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.990200E-01
Normal-vs-N1
9.688800E-01
N0-vs-N1
8.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.524400E-01
Normal-vs-TP53-NonMutant
7.789000E-01
TP53-Mutant-vs-TP53-NonMutant
2.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
